Rational use of antibiotics for pneumonia: India Clinical Epidemiology Network (INDIACLEN) task force on pneumonia

Indian Pediatrics

Volumn 47, Issue 1, 2010, Pages 11-18

  Arora, Narendera K ^a  

^a Okhla Industrial Area   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; PENICILLIN G; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABSCESS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; CYANOSIS; DETERIORATION; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG INDUSTRY; DRUG SPECIFICITY; DRUG USE; DRUG UTILIZATION; DYSPNEA; EARLY DIAGNOSIS; EMPYEMA; FEVER; FOLLOW UP; FURUNCULOSIS; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INDIA; LETHARGY; MALARIA; MALNUTRITION; MEASLES; MEDICAL PRACTICE; MENINGITIS; MONITORING; MORBIDITY; MORTALITY; PATIENT EDUCATION; PENICILLIN RESISTANCE; PNEUMATOCELE; PNEUMONIA; PRESCRIPTION; PREVALENCE; RESPIRATORY DISTRESS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RISK REDUCTION; RURAL AREA; SEPTICEMIA; SOCIOECONOMICS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; VOMITING; WHEEZING;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DECISION TREES; HUMANS; PNEUMONIA, BACTERIAL;

EID: 74749090549     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: 10.1007/s13312-010-0015-4     Document Type: Article

References (19)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE; WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 2005; 365: 1147-1152.
2. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86: 408-416.
3. UNICEF. Pneumonia: The Forgotten Killer of Children. The United Nations Children's Fund (UNICEF)/World Health Organization (WHO), 2006. Available from: URL: http:// www.unicef.org/publications/files/ Pneumonia-The-Forgotten-Killer- of-Children.pdf. Accessed August 30, 2009.
4. International Institute for Population Sciences (IIPS) and Macro International. 2007. National Family Health Survey (NFHS-3), 2005-06: India: Volume I. Mumbai: IIPS. p. 223-266.
5. UNICEF: Progress for Children: A World Fit for Children Statistical Review. United Nations Children's Fund, 2007. Available from: URL: http:/ /www.unicef.org/progressforchildren/2007n6/ files/Progress-for-Children---No.-6. pdf.
6. Sharma R, Chopra VS, Kour G. Use of antibiotics for respiratory illnesses in rural India. J Clin Diag Res 2009; 3: 1557-1561.
7. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Lancet 1999; 353: 1216-1221.
8. Steinhoff MC, Thomas K, Lalitha MK, for the Invasive Bacterial Infections Surveillance Group of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. Clin Infect Dis 2002; 34: 949-957.
9. Zeitz PS, Harrison LH, López M, Cornale G. Community health worker competency in managing acute respiratory infections of childhood in Bolivia. Bull Pan Am Health Organ 1993; 27: 109-119.
10. Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, MacLeod WB, et al. New Outpatient Short-Course Home Oral Therapy for Severe Pneumonia Study Group. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 2008; 371: 49-56.
11. Awasthi S, Agarwal G, Kabra SK, Singhi S, Kulkarni M, More V, et al. Does 3-day course of oral amoxicillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial. PLoS One 2008; 3: e1991.
12. Sachdev HPS, Mahajan SC, Garg A. Improving antibiotic and bronchodilator prescription in children presenting with difficult breathing: experience from an urban hospital in India. Indian Pediatr 2001; 38: 827-838.
13. Asghar R, Banajeh S, Egas J, Hibberd P, Iqbal I, Katep-Bwalya M, et al. Multicentre randomized controlled trial of chloramphenicol vs. ampicillin and gentamicin for the treatment of very severe pneumonia among children aged 2 to 59 months in low resource settings: a multicenter randomized trial (spear study). BMJ 2008; 336: 80-84.
14. Kanungo R, Rajalakshmi B. Serotype distribution and antimicrobial resistance in Streptococcus pneumoniae causing invasive and other infections in south India. Indian J Med Res 2001; 114: 127-132.
15. Blondeau JM, Tillotson GS. Antimicrobial susceptibility patterns of respiratory pathogens - a global perspective. Semin Respir Infect 2000; 15: 195-207.
16. Kabra SK, Lodha R, Pandey RM. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 2006; 3: CD004874.
17. Awasthi S, Agarwal G, Singh JV, Kabra SK, Pillai RM, Singhi S, et al., for ICMR-IndiaClen Pneumonia Project Group. Effectiveness of 3-day amoxicillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial. J Trop Pediatr 2008; 54: 382-389.
18. Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008; 2: CD005976.
19. Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al., for APPIS Group. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomized multicentre equivalency study. Lancet 2004; 364: 1141-1148.